Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses

The ability to predict responsiveness to drugs in individual patients is limited. We hypothesized that integrating molecular information from databases would yield predictions that could be experimentally tested to develop transcriptomic signatures for specific drugs. We analyzed lung adenocarcinoma...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Oncol
Main Authors: Tavassoly, Iman, Hu, Yuan, Zhao, Shan, Mariottini, Chiara, Boran, Aislyn, Chen, Yibang, Li, Lisa, Tolentino, Rosa E., Jayaraman, Gomathi, Goldfarb, Joseph, Gallo, James, Iyengar, Ravi
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2019
Assuntos:
Research Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6670022/
https://ncbi.nlm.nih.gov/pubmed/31116490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12521
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares